Anita Moser, Michael Davis, Dharmendra Sahay outline UCB's measured approach to scaling its AI capabilities.
Anita Moser, Michael Davis, Dharmendra Sahay
Advertisement
Anita Moser is UCB’s head of assets and optimization for US Neurology. Michael Davis leads UCB’s US Neurology Patient Value Unit. Dharmendra Sahay leads ZS’s integrated analytics practice.
Articles by Anita Moser, Michael Davis, Dharmendra Sahay
Advertisement
Latest Updated Articles
How UCB Transformed into a More Agile, Data-Driven OrganizationPublished: March 13th 2020 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
FDA Appoints Tracy Beth Høeg as Acting Director of CDER
2
Pharmaceutical Executive Daily: FDA Names Tracy Beth Høeg as Acting Director of CDER
3
Regeneron Announces $150 Million Collaboration with Tessera Therapeutics to Develop Gene Editing Therapy
4
Reshaping Kidney Care: Q&A with Stylianos Sarrigiannidis
5
